RecruitingPhase 4NCT06045936

A Study of Contralateral Limb Block

Sciatic Block in Contralateral Limb for Treatment of Refractory Phantom and Residual Limb Pain; a Double-Blind Randomized Controlled Trial


Sponsor

Mayo Clinic

Enrollment

20 participants

Start Date

Jun 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This research is being done to determine if an anesthetic like Lidocaine, may be effective when injected around the sciatic nerve of the intact limb in patients with limb loss pain on the contralateral side.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Lower extremity amputation performed more than 12 months before study enrollment
  • PLP/RLP in affected amputated limb > 4 on NRS26
  • Pain duration of more than 6 months despite a trial of conservative therapies for at least 2 months, including oral medications, topical medicines, physical therapy, and physical modalities (i.e., heat, cold, transcutaneous electrical nerve stimulation, phonophoresis)
  • Willingness to undergo image guided diagnostic nerve block

Exclusion Criteria7

  • Refusal / inability to participate or provide consent
  • Contraindications to diagnostic nerve block
  • Non-neurogenic source of PLP/RLP
  • Current opioid use > 50 morphine milligram equivalents per day
  • Any interventional pain treatment in the residual limb within the last 30 days
  • Severe uncontrolled medical condition (i.e., hypertensive crisis, decompensated hypothyroidism)
  • Use of investigational pain drug within past 30 days or other concurrent clinical trial enrollment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLidocaine

2 teaspoons of 2% lidocaine injection

DRUGPlacebo

Saline injection


Locations(1)

Mayo Clinic Health System - Mankato

Mankato, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06045936


Related Trials